Fusion Global Energy Starts Delivery of Commercial Fusion Energy and Grid-Less Power Distribution
FGE (Fusion Global Energy) is fielding an operational nuclear fusion energy system in April 2025 with a capacity of delivery throughout the USA and Europe. The system currently deployed has an installed capacity of 2,500 terawatt-hours (TWh) in the United States and 300 TWh in Europe. Fusion energy is, by nature, green, without harmful greenhouse emissions and relies on cheap and virtually unlimited fuels such as hydrogen and helium isotopes.
In parallel, the company has introduced its Quantum Energy Teleportation (QET) distribution system, a technology that enables instantaneous, high- efficiency energy transmission. In April 2025, four industrial-scale QET units, rated at 500 kV (3,400 MVA), each capable of delivering 52 gigawatt-hours (GWh), are being installed across the continental United States. The QET system is expected to reduce logistics and implementation time by eliminating the need for conventional power grids and long-distance transmission infrastructure.
For industrial users, the 500 kV QET system provides a direct, 99% reliable and high-capacity energy source capable of meeting the demands of large-scale manufacturing and infrastructure projects. Meanwhile, a retail version of QET, designed for residential and small-business applications, is coming online this April. These units, available in 10 to 300 kilowatt-hour (kWh) configurations, offer consumers access to on-demand, high-efficiency power for a monthly subscription, with a flat rate (independent of peak or off-peak hours) starting at 0.15$ / kWh.
To facilitate adoption of QET power distribution, residential QET reception units will be made available through major retail distributors. During April, consumers in both the United States and Europe will be able to purchase such units through various online and in-store vendors, ensuring seamless access to quantum energy technology. The system requires no licensing and can be installed through standard electrical connections. Excess power can be sold back to the grid in some States, depending local legislation.
The launch of commercial nuclear fusion and QET distribution represents strong potential towards providing a clean, decentralised power source, this technology is expected to lower energy costs, enhance grid resilience, and contribute to international carbon reduction goals.
About Fusion Global Inc.
Fusion Global Inc. specialises in next-generation energy solutions, high energy plasma physics, quantum mechanics, and nuclear fusion technologies. With a commitment to innovation, efficiency, and global accessibility, the company aims to evolve the way the world generates, distributes and consumes electricity. For more information, visit www.fusionglobalenergy.com.
Media Contact:
Nick Goldberg
Fusion Global Energy Inc (NY-NY)
www.fusionglobalenergy.com
Contact Information:
Fusion Global Energy
Nick Goldsmith
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
23 minutes ago
- Associated Press
Kaplan Fox Investigates Inspire Medical Systems, Inc. (INSP) After Stock Drops 32% on Reduced 2025 Outlook
NEW YORK, NY - August 18, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Inspire Medical Systems. ('Inspire' or the 'Company') (NYSE: INSP). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Inspire investor and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003. On August 4, 2025, after markets closed, Inspire issued a press release announcing its second quarter financial results and updating its 2025 outlook. Inspire reduced both its 2025 full-year revenue outlook and diluted net income per share. The Company attributed the reductions in 2025 guidance to the 'slower than expected' U.S. commercial launch of the next generation Inspire V neurostimulation system. Following this news, the price of Inspire stock fell $42.04 per share, or 32.35%, to close at $87.91 per share on August 5, 2025. WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this investigation, please contact: CONTACT: Pamela A. Mayer KAPLAN FOX & KILSHEIMER LLP 800 Third Avenue, 38th Floor New York, New York 10022 (646) 315-9003 [email protected] Laurence D. King KAPLAN FOX & KILSHEIMER LLP 1999 Harrison Street, Suite 1560 Oakland, California 94612 (415) 772-4704 [email protected] Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
Yahoo
7 hours ago
- Yahoo
Hackensack Meridian Health and CLEAR Partner to Bring Secure, Seamless Digital Identity to the Patient Experience
New Jersey's Largest Health Network – and Home of the #1 Hospital in the NY/NJ Metro Area according to U.S. News & World Report, 2025-26 – Becomes First in Tri-State to Deploy CLEAR for Seamless Appointment Check-In and Medical Record Access EDISON, N.J. and NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The era of juggling clipboards, insurance cards, and identification at hospitals and in doctors' waiting rooms is going to change for patients at Hackensack Meridian Health. New Jersey's largest and most comprehensive health network announced a groundbreaking partnership with CLEAR (NYSE: YOU), the secure identity company, to power a single, interoperable identity designed for faster and more convenient patient experiences across the Hackensack ecosystem. Hackensack plans to leverage CLEAR's identity platform, CLEAR1, via its integration with Epic, to enable MyChart Account Creation and Password Reset. Once live, patients will be able to verify their identity with a quick selfie, bypassing legacy solutions and traditional paperwork. Additionally, this seamless verification process is expected to be available for Patient Check-In on kiosks at select Hackensack locations. 'Hackensack Meridian Health is fundamentally changing what it means to be a patient, starting at the front door,' said Robert C. Garrett, FACHE, Chief Executive Officer of Hackensack Meridian Health. 'Our partnership with CLEAR will make the check-in process as simple and secure as CLEAR's experience at the airport. This is a powerful example of how we leverage world-class technology to enhance the patient experience, improve access, and truly reimagine healthcare for our communities.' Integrating CLEAR1 provides a dual benefit, enhancing patient experience while delivering significant operational advantages for the health network. The partnership will not only streamline digital identity verification but also reinforce a commitment to security and patient trust. 'CLEAR's mission is to make experiences safer and easier by connecting you to your secure identity,' said Caryn Seidman Becker, CEO of CLEAR. 'With over 33 million Members, we're proud to bring our trusted identity platform to healthcare where speed, trust, and security are paramount. Our partnership with Hackensack Meridian Health is transforming patient check-in from a friction-filled moment into a seamless, secure experience. Together, we're helping people get to the care they need, faster, easier, and with greater peace of mind.' Hackensack plans to first roll out MyChart Account Creation and Password Reset, enabling a seamless and secure way for patients to create and access their account and health information. Next, John Theurer Cancer Center (JTCC) at Hackensack University Medical Center, one of the top 20 hospitals in the nation, according to U.S. News & World Report 2025-26, expects to launch CLEAR's Check In experience. As the first cancer center in the country to use this technology, patients will be able to check in for their appointment by simply snapping a photo at a kiosk. This technology will also be available at Hackensack Meridian Health and Wellness Center in Eatontown, New Jersey, before expanding more widely across the network. Hackensack Meridian Health and CLEAR, with a shared mission and values to foster meaningful change in healthcare, will continue to look for innovative ways to expand the partnership and continue to deliver world-class, accessible care to our patients and the communities we serve. About HACKENSACK MERIDIAN Hackensack Meridian Health is a leading not-for-profit health care organization and New Jersey's largest, most comprehensive, and integrated health network. Our network includes 18 hospitals, more than 500 patient care locations, and a complete range of services from innovative research and life-enhancing care to lifesaving air medical transportation. Our 38,000 team members and 7,000 physicians are committed to the health and well-being of the communities we serve, making Hackensack Meridian Health a distinguished leader in healthcare philanthropy. Hackensack University Medical Center is the first-ever New Jersey hospital to be ranked a Top 20 hospital in the nation. It is also ranked #1 in New Jersey and the New York metro area by U.S. News & World Report, 2025-26. Hackensack Meridian Health is proud to be home to New Jersey's #1 children's hospital and the state's only nationally-ranked cancer center, the John Theurer Cancer Center. To learn more, visit About CLEARCLEAR's mission is to strengthen security and create frictionless experiences. With over 33 million Members and a growing network of partners across the world, CLEAR's secure identity platform is transforming the way people live, work, and travel. Whether you are traveling, at the stadium, or on your phone, CLEAR connects you to the things that make you, you – making everyday experiences easier, more secure, and friction-free. CLEAR is committed to privacy done right. Members are always in control of their own information, and we never sell Member data. For more information, visit Forward-Looking StatementsThis release may contain statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This includes, without limitation, statements related to CLEAR's planned integrations and the impact on the patient experience. Investors are cautioned that any and such forward-looking statements are not guarantees of future performance or results and involve risks and uncertainties, and that actual results, developments and events may differ materially from those in the forward-looking statements as a result of various factors, including risks associated with the integration process and those described in the Company's filings within the Securities and Exchange Commission, including the sections titled "Risk Factors" in our Annual Report on Form 10- K. The Company disclaims any obligation to update any forward-looking statements contained herein. CLEARmedia@ This press release was published by a CLEAR® Verified in to access your portfolio
Yahoo
3 days ago
- Yahoo
Sugar Prices Continue to Fall Back From Tuesday's 2-month High
October NY world sugar #11 (SBV25) on Friday closed down -0.14 (-0.84%), and October London ICE white sugar #5 (SWV25) closed down -8.20 (-1.68%). NY sugar prices on Friday saw continued long liquidation pressure after the rally up to Tuesday's 2-month high. More News from Barchart Coffee Prices Extend Wednesday's Rally Coffee Prices Extend Wednesday's Rally Grain Market Update: Could a Rate Cut, Inflation Spur Fund Buying in Wheat, Soybeans, and Corn? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! As a bullish factor, Unica Friday reported that Brazil's Center-South sugar output in the second half of July fell by -0.8% y/y to 3,614 MT, and the 2025-26 Center-South sugar output through July fell -7.8% y/y to 19,268 MT. The percentage of sugarcane crushed for sugar by Brazil's sugar mills in the second half of July increased to 54.10% from 50.32% the same time last year. The outlook for higher sugar exports from India is negative for sugar prices after Bloomberg reported that India may permit local sugar mills to export sugar in the next season, which starts in October, as abundant monsoon rains may produce a bumper sugar crop. India's Meteorological Department reported Tuesday that cumulative monsoon rain in India was 500.8 mm as of August 4, or 4% above normal. Also, the Indian Sugar and Bio-energy Manufacturers Association said last Thursday that it will seek permission to export 2 MMT of sugar in 2025/26. The outlook for higher sugar production in India, the world's second-largest producer, is bearish for prices. On June 2, India's National Federation of Cooperative Sugar Factories projected that India's 2025/26 sugar production would climb +19% y/y to 35 MMT, citing larger planted cane acreage. That would follow a -17.5% y/y decline in India's sugar production in 2024/25 to a 5-year low of 26.2 MMT, according to the Indian Sugar Mills Association (ISMA). Sugar prices retreated through early July, with NY sugar falling to a 4.25-year low and London sugar sliding to a 4-year low, driven by expectations of a sugar surplus in the 2025/26 season. On June 30, commodities trader Czarnikow projected a 7.5 MMT global sugar surplus for the 2025/26 season, the largest surplus in 8 years. On May 22, the USDA, in its biannual report, projected that global 2025/26 sugar production would increase by +4.7% y/y to a record 189.318 MMT, with global sugar ending stocks at 41.188 MMT, up 7.5% y/y. Sugar prices also have support from reduced sugar production in Brazil. Unica reported last Thursday that the cumulative 2025/26 Brazil Center-South sugar output through mid-July fell by -9.2% y/y to 15.655 MMT. Last month, Conab, Brazil's government crop forecasting agency, said 2024/25 Brazil sugar production fell by -3.4% y/y to 44.118 MMT, citing lower sugarcane yields due to drought and excessive heat. The outlook for higher sugar production in Thailand is bearish for sugar prices. On May 2, Thailand's Office of the Cane and Sugar Board reported that Thailand's 2024/25 sugar production rose +14% y/y to 10.00 MMT. Thailand is the world's third-largest sugar producer and the second-largest exporter of sugar. The International Sugar Organization (ISO) raised its 2024/25 global sugar deficit forecast to a 9-year high of -5.47 MMT on May 15, up from a February forecast of -4.88 MMT. This indicates a tightening market following the 2023/24 global sugar surplus of 1.31 MMT. ISO also cut its 2024/25 global sugar production forecast to 174.8 MMT from a February forecast of 175.5 MMT. The USDA, in its bi-annual report released May 22, projected that global 2025/26 sugar production would climb +4.7% y/y to a record 189.318 MMT and that global 2025/26 human sugar consumption would increase +1.4% y/y to a record 177.921 MMT. The USDA also forecasted that 2025/26 global sugar ending stocks would climb +7.5% y/y to 41.188 MMT. The USDA's Foreign Agricultural Service (FAS) predicted that Brazil's 2025/26 sugar production would rise +2.3% y/y to a record 44.7 MMT FAS predicted that India's 2025/26 sugar production would rise +25% y/y to 35.3 MMT due to favorable monsoon rains and increased sugar acreage. FAS predicted that Thailand's 2025/26 sugar production will climb +2% y/y to 10.3 MMT. On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
